Choice Genetics
FarmingFrance, France51-200 Employees
Choice Genetics est la branche porcine du groupe Grimaud, N° 2 mondial en génétique animale et biopharmacie.
Geographic Expansion Choice Genetics is actively expanding its presence internationally, evidenced by recent hires such as Tomi Olatunde as Sales and Technical Manager for Africa. This focus on geographic growth suggests opportunities for sales of genetic products and services in emerging markets across Africa.
Product Innovation The launch of the P81 terminal sire in 2018 indicates a commitment to innovative genetic solutions. There is potential to cross-sell new or similar advanced genetic traits to existing clients seeking improved productivity and genetic traits.
Market Position As a branch of Grimaud, the second-largest global player in animal genetics and biopharmaceutics, Choice Genetics benefits from a strong industry position. This affiliation can be attractive to customers seeking reputable and technologically advanced genetic solutions.
Technology Leverage The company's integration of various digital tools such as Google Analytics and SEO strategies indicates an active digital presence, providing channels for targeted marketing campaigns and lead generation opportunities within the farming industry.
Financial Growth With revenue estimates between 10 million and 25 million dollars and recent strategic hires, there is room for growth and upselling high-value genetic solutions and consultancy services to larger farms and industry players aiming to improve genetic performance.
Choice Genetics uses 8 technology products and services including RSS, JSS, Backbone.js, and more. Explore Choice Genetics's tech stack below.
| Choice Genetics Email Formats | Percentage |
| First.Last@choice-genetics.com | 47% |
| FL@choice-genetics.com | 5% |
| First.MiddleLast@choice-genetics.com | 1% |
| First.Last@choice-genetics.com | 47% |
FarmingFrance, France51-200 Employees
Choice Genetics est la branche porcine du groupe Grimaud, N° 2 mondial en génétique animale et biopharmacie.
Choice Genetics's revenue is estimated to be in the range of $10M$25M
Choice Genetics's revenue is estimated to be in the range of $10M$25M